Phase I trial of AVN-101 for treatment of Alzheimer's disease.
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2010
At a glance
- Drugs AVN 101 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
- 01 Jan 2010 Results will be presented at ICAD 2010 in July, according to an Avineuro Pharmaceuticals media release.
- 03 Nov 2008 New trial record.